Effect of ethanolamine salts and enhancers on the percutaneous absorption of piroxicam from a pressure sensitive adhesive matrix

被引:17
作者
Cheong, HA [1 ]
Choi, HK [1 ]
机构
[1] Chosun Univ, Coll Pharm, Dong Gu, Kwangju 501759, South Korea
基金
新加坡国家研究基金会;
关键词
salt; piroxicam; PSA matrix; enhancer; permeability;
D O I
10.1016/S0928-0987(02)00254-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of salt formation on the percutaneous absorption of piroxicam through hairless mouse skin from a pressure sensitive adhesive (PSA) matrix were investigated. We also studied the effect of permeation enhancers on the skin permeation of piroxicam or piroxicam-ethanolamine (PX-EA) salts from an acrylic adhesive matrix. The order of the permeation rates of piroxicam and PX-EA salts from the PSA matrix was piroxicam-monoethanolamine salt (PX-MEA)>piroxicam-diethanolamine salt (PX-DEA)>piroxicam> piroxicam-triethanolamine salt (PX-TEA). The enhancer Crovol((R)) A40 provided the highest piroxicam and PX-MEA fluxes and Plurol oleque((R)) the highest PX-DEA and PX-TEA fluxes. The order of piroxicam and PX-EA salts permeabilities were different for saturated solutions in various enhancers and PSA matrix containing the same enhancer, especially when Crovol A40, Crovol((R)) PK40 or Plurol oleque were used as enhancers. No close relationship was found between the fluxes of piroxicam or PX-EA salts from saturated solutions and from PSA matrices containing the same enhancer. Maximum piroxicam flux was obtained when PX-MEA/PX-TEA (4:6, v/v) was incorporated into a PSA matrix containing Crovole PK40. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:149 / 153
页数:5
相关论文
共 12 条
[1]   Enhanced percutaneous absoption of piroxicam via salt formation with ethanolamines [J].
Cheong, HA ;
Choi, HK .
PHARMACEUTICAL RESEARCH, 2002, 19 (09) :1375-1380
[2]   Enhancement of percutaneous absorption of ketoprofen: effect of vehicles and adhesive matrix [J].
Cho, YJ ;
Choi, HK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 169 (01) :95-104
[3]   Transdermal delivery of antiparkinsonian agent, benztropine. I. Effect of vehicles on skin permeation [J].
Gorukanti, SR ;
Li, LL ;
Kim, KH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 192 (02) :159-172
[4]   Ion pair skin transport of a zwitterionic drug, cephalexin [J].
Hatanaka, T ;
Kamon, T ;
Morigaki, S ;
Katayama, K ;
Koizumi, T .
JOURNAL OF CONTROLLED RELEASE, 2000, 66 (01) :63-71
[5]  
LEE SJ, 1987, INT J PHARM, V39, P59
[6]   Formulation study of a transdermal delivery system of primaquine [J].
Mayorga, P ;
Puisieux, F ;
Couarraze, G .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 132 (1-2) :71-79
[7]   THE TRANSDERMAL DELIVERY OF ZWITTERIONIC DRUGS .1. THE SOLUBILITY OF ZWITTERION SALTS [J].
MAZZENGA, GC ;
BERNER, B .
JOURNAL OF CONTROLLED RELEASE, 1991, 16 (1-2) :77-88
[8]   THE TRANSDERMAL DELIVERY OF ZWITTERIONIC DRUGS .2. THE FLUX OF ZWITTERION SALTS [J].
MAZZENGA, GC ;
BERNER, B ;
JORDAN, F .
JOURNAL OF CONTROLLED RELEASE, 1992, 20 (02) :163-170
[9]   Ion-pair formation as a strategy to enhance topical delivery of salicylic acid [J].
Megwa, SA ;
Cross, SE ;
Benson, HAE ;
Roberts, MS .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (08) :919-928
[10]   A PREDICTIVE ALGORITHM FOR SKIN PERMEABILITY - THE EFFECTS OF MOLECULAR-SIZE AND HYDROGEN-BOND ACTIVITY [J].
POTTS, RO ;
GUY, RH .
PHARMACEUTICAL RESEARCH, 1995, 12 (11) :1628-1633